PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New treatment strategy for epilepsy

Chemical chaperones correct the misfolding of the mutant protein

New treatment strategy for epilepsy
2014-12-09
(Press-News.org) Researchers found out that the conformational defect in a specific protein causes Autosomal Dominant Lateral Temporal Lobe Epilepsy (ADLTE) which is a form of familial epilepsy. They showed that treatment with chemical corrector called "chemical chaperone" ameliorates increased seizure susceptibility in a mouse model of human epilepsy by correcting the conformational defect. This was published in Nature Medicine (December 8, 2014 electronic edition).

Mutations in the gene LGI1, encoding a secreted protein, cause familial temporal lobe epilepsy. The research group of Professor Masaki Fukata, Associate Professor Yuko Fukata, and Assistant Professor Norihiko Yokoi of the National Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences (NINS), in collaboration with the group of Professor Masahiko Watanabe of the Hokkaido University Graduate School of Medicine, Professor Dies Meijer of the Erasmus University Medical Center in the Netherlands, and Professor Takao Hamakubo of the Research Center for Advanced Science and Technology, The University of Tokyo, investigated 22 mutations in the LGI1 gene found in patients with human epilepsy. In 19 mutations, LGI1 mutant protein was secretion-defective. One of these mutations was introduced to mice which produced symptoms of epilepsy. In LGI1 mutant mice, there was a decrease in the amount of LGI1 functioning normally outside the cell (i.e., synapse) due to the degradation by an intrinsic quality control system that rapidly degrades and eliminates mutant proteins.

A small molecule called chemical chaperone (4-phenylbutyrate) was administrated to LGI1 mutant mice with a view to correct the misfolding of the LGI1 mutant protein and to cause normal secretion to the synapse. It was found that the mice had decreased seizure susceptibility.

Epilepsy is a common brain disorder that affects 1% of the population. In some cases, current antiepileptic drugs have a limited role in the treatment. According to Professor Masaki Fukata, "Chemical chaperone treatment focused on correcting the misfolding in proteins has been tried in inherited diseases including cystic fibrosis and lysosome disease. This is the first for chemical chaperones to be applied as a therapeutic option for epilepsy. The same therapeutic strategy may also be of benefit to epilepsy caused by genetic mutations other than LGI1 gene. We propose a novel therapeutic strategy for epilepsy."

INFORMATION:


[Attachments] See images for this press release:
New treatment strategy for epilepsy

ELSE PRESS RELEASES FROM THIS DATE:

Turning biological cells to stone improves cancer and stem cell research

Turning biological cells to stone improves cancer and stem cell research
2014-12-09
ALBUQUERQUE, N.M. -- Changing flesh to stone sounds like the work of a witch in a fairy tale. But a new technique to transmute living cells into more permanent materials that defy rot and can endure high-powered probes is widening research opportunities for biologists who are developing cancer treatments, tracking stem cell evolution or even trying to understand how spiders vary the quality of the silk they spin. The simple, silica-based method also offers materials scientists the ability to "fix" small biological entities like red blood cells into more commercially ...

The winds of Titan

The winds of Titan
2014-12-09
As sand dunes march across the Sahara, vast dunes cross the surface of Saturn's largest moon, Titan. New research from a refurbished NASA wind tunnel reveals the physics of how particles move in Titan's methane-laden winds and could help to explain why Titan's dunes form in the way they do. The work is published online Dec. 8 in the journal Nature. "Conditions on Earth seem natural to us, but models from Earth won't work elsewhere," said Bruce White, professor of mechanical and aerospace engineering at the University of California, Davis, and a co-author on the study. ...

Smoking still causes large proportion of cancer deaths in the United States

2014-12-09
ATLANTA - December 9, 2014- A new American Cancer Society study finds that despite significant drops in smoking rates, cigarettes continue to cause about three in ten cancer deaths in the United States. The study, appearing in the Annals of Epidemiology, concludes that efforts to reduce smoking prevalence as rapidly as possible should be a top priority for the U.S. public health efforts to prevent cancer deaths. More than 30 years ago, a groundbreaking analysis by famed British researchers, Richard Doll and Richard Peto, calculated that 30 percent of all cancer deaths ...

Paying attention makes touch-sensing brain cells fire rapidly and in sync

2014-12-09
Whether we're paying attention to something we see can be discerned by monitoring the firings of specific groups of brain cells. Now, new work from Johns Hopkins shows that the same holds true for the sense of touch. The study brings researchers closer to understanding how animals' thoughts and feelings affect their perception of external stimuli. The results were published Nov. 25 in the journal PLoS Biology. "There is so much information available in the world that we cannot process it all," says Ernst Niebur, Ph.D., a professor of neuroscience in the Johns Hopkins ...

Storing hydrogen underground could boost transportation, energy security

Storing hydrogen underground could boost transportation, energy security
2014-12-09
LIVERMORE, Calif. -- Large-scale storage of low-pressure, gaseous hydrogen in salt caverns and other underground sites for transportation fuel and grid-scale energy applications offers several advantages over above-ground storage, says a recent Sandia National Laboratories study sponsored by the Department of Energy's Fuel Cell Technologies Office. Geologic storage of hydrogen gas could make it possible to produce and distribute large quantities of hydrogen fuel for the growing fuel cell electric vehicle market, the researchers concluded. Geologic storage solutions ...

Stroke: Promising results of an important study published in the scientific journal Brain

Stroke: Promising results of an important study published in the scientific journal Brain
2014-12-09
Neuro-rehabilitation (physical therapy, occupational therapy, etc.) helps hemaparetic stroke patients confronted with loss of motor skills on one side of their body, to recover some of their motor functions after a cerebrovascular accident. One of the most promising tracks in neuro-rehabilitation consists in amplifying the motor learning ability after a stroke, in other words how to learn (again) how to make movements with the parts of the human body impacted after a stroke. Pilot studies have shown at this matter that tDCS (transcranial direct current stimulation) - ...

Ancient balloon-shaped animal fossil sheds light on Earth's ancient seas

Ancient balloon-shaped animal fossil sheds light on Earths ancient seas
2014-12-09
Nidelric pugio fossil dates to half a billion years ago and teaches us about the diversity of life in Earth's ancient seas In life the animal was a 'balloon' shape and was covered in spines, but the squashed fossil resembles a bird's nest Named in honour of Professor Richard Aldridge from the University of Leicester A rare 520 million year old fossil shaped like a 'squashed bird's nest' that will help to shed new light on life within Earth's ancient seas has been discovered in China by an international research team - and will honour the memory of a University of ...

Data published on ANG4043, anti-HER2 monoclonal antibody for treatment of brain metastases

2014-12-09
Montreal, Canada, November x, 2014 - Angiochem, a clinical stage biotechnology company creating and developing drugs that cross the blood-brain barrier, today announced the publication in Molecular Cancer Therapeutics demonstrating that ANG4043, a peptide-monoclonal antibody (mAb) conjugate, entered the brain at therapeutic concentrations, resulting in significantly prolonged survival in mice. The antibody is directed against HER2, which is the protein targeted by Herceptin®. Because the mAb is conjugated to Angiopep-2, it is recognized by the LRP1 receptor and takes ...

Sleep disturbance linked to amyloid in brain areas affected by Alzheimer's disease

2014-12-09
Phoenix, AZ (December 9th, 2014) - Healthy, elderly research participants who report being more sleepy and less rested have higher levels of amyloid deposition in regions of the brain that are affected in Alzheimer's disease, according to a report presented today at the American College of Neuropsychopharmacology annual meeting in Phoenix (Arizona). If sleep disturbance is a cause of amyloid accumulation, it may be an early target for intervention to prevent the progression of cognitive deficits in late life. Numerous studies have shown the importance of sleep and the ...

Brain scans link frontal abnormalities to suicidal behaviors in adolescents, young adults

2014-12-09
Phoenix, AZ (December 9th, 2014) - Abnormalities in the prefrontal cortex and related brain areas are observed in adolescents who have attempted suicide, according to a report today at the American College of Neuropsychopharmacology annual meeting in Phoenix Arizona. The study suggests that deficits in frontal systems may be associated with risk for suicide attempts in youths with mood disorders. Most suicide attempts occur in the context of mood disorders, including bipolar disorder and major depressive disorder. Bipolar disorder has a prevalence of 3-4% in the U.S. population, ...

LAST 30 PRESS RELEASES:

Direct discharge electrical pulses for carbon fiber recycling

Scientists uncover rapid-acting, low-side-effect antidepressant target

Diamond continues to shine: new properties discovered in diamond semiconductors

Researchers find the key to Artificial Intelligence’s learning power – an inbuilt, special kind of Occam’s razor

Genetic tweak optimizes drug-making cells by blocking buildup of toxic byproduct

University of Birmingham researchers awarded grant to tackle early-stage heart disease in chronic kidney disease

Researchers harness AI to predict cardiovascular risk from CT scans

Samsung takes top spot in U.S. patents for third year running while TSMC rises into second place; after four-year falloff, grants increase nearly 4%

HKU ecologist highlights critical gaps in global wildlife trade monitoring

Smoking may lead people to earn less

Hiroshima flooding: A case study of well usage and adaptive governance

New survey finds over half of Americans are unaware that bariatric surgery can improve fertility

World’s oldest 3D map discovered

Metabolomics-driven approaches for identifying therapeutic targets in drug discovery

Applications of ultrafast nano-spectroscopy and nano-imaging

Study links PFAS contamination of drinking water to a range of rare cancers

Scientists explain how a compound from sea sponge exerts its biological effects

Why older women are embracing the open road

Shift to less reliable ‘natural’ contraception methods among abortion patients over past 5 years

Tobacco advertising + sponsorship bans linked to 20% lower odds of smoking

Vascular ‘fingerprint’ at the back of the eye can accurately predict stroke risk

Circulation problems in the brain’s seat of memory linked to mild cognitive impairment in older adults

Oregon State receives $11.9 million from Defense Department to enhance health of armed forces

Leading cancer clinician, researcher Dr. Jenny Chang to lead Houston Methodist Academic Institute

Engineering quantum entanglement at the nanoscale

Researchers develop breakthrough one-step flame retardant for cotton textiles

New study identifies how blood vessel dysfunction can worsen chronic disease

Picking the right doctor? AI could help

Travel distance to nearest lung cancer facility differs by racial and ethnic makeup of communities

UTA’s student success strategy earns national acclaim

[Press-News.org] New treatment strategy for epilepsy
Chemical chaperones correct the misfolding of the mutant protein